Current Oncology News and Info – July 2024

/0 Comments/in , /by
We are happy to help share the latest Current Oncology Society Newsletter outlining some key important updates relevant to the ARCC Community. Download PDF Version. Key Highlights:  Updated 2024 Impact Factor; CO is pleased to receive an increased Impact Factor of 2.8 in the 2023 Journal Citation Reports™ released by (more…)

ARCC’s new Partnership with Current Oncology

/0 Comments/in , , /by
We are excited to announce a new partnership with Current Oncology whereby ARCC members will receive author fee discounts when publishing in this important jounal. Please email karen.irwin@mdpi.com for more details. Current Oncology (ISSN 1718-7729) is an international, peer-reviewed, open access journal published online by MDPI (from Volume 28 Issue 1-2021). Established in 1994, (more…)

CCTG IC.8 COV-IMMUNO- A randomized phase III trial of immunization with IMM-101 versus observation for the prevention of serious respiratory and COVID-19 related infections in cancer patients at increased risk of exposure

/1 Comment/in /by
Lead Investigator(s): Rebecca Auer (The Ottawa Hospital), Chris O’Callaghan (Queen’s University) Co-Investigators: John Bartlett, Laszlo Radvanyi, Dongsheng Tu, Janet Dancey, Scott Halperin, Kelvin Chan, Nicole Mittmann, Martin Smoragiewicz, Grainne O’Kane, George Zogopoulos, Jonathon Loree, Rosalyn Juergens, Eric Winquist, Judy Needham, David Roberge ARCC Program Area(s): Health Technology Assessment Main Funder/Other (more…)
The Canadian Centre for Applied Research in Cancer Control

Assessing the Real-World Clinical and Economic Outcomes of Emerging Innovative Technologies in Oncology: The Cases of Biosimilars and CAR T-cells

/0 Comments/in /by
Lead Investigator(s): Kelvin Chan, Scott Gavura, Wanrudee Isaranuwatchai Lead Institution: Sunnybrook Research Institute Co-Investigators: Jaclyn Beca, Wei Fang Dai, Jessica Arias, Lisa Milgram, Elaine Meertens, Arthur Manzon, Sherrie Hertz, Sean Hopkins, Tom Kouroukis, Chris Bredeson, William Wai Lun Wong, Petros Pechlivanoglou, Pierre Villeneuve, Sumit Gupta, Alexandra Chambers, Christine Chen, Lee (more…)
The Canadian Centre for Applied Research in Cancer Control

CanREValue: Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada

/0 Comments/in /by
  Lead Investigator(s): Kelvin Chan, Stuart Peacock, Wanrudee Isaranuwatchai, Mina Tadrous, Michael Sherar Lead Institution: Sunnybrook Research Institute Co-Investigators: Riaz Alvi, Jaclyn Beca, Yvonne Bombard, Melissa Brouwers, Winson Cheung, Janet Dancey, Claire de Oliveira, Craig Earle, Jeffrey Hoch, Robin McLeod, Nicole Mittmann, Petros Pechlivanoglou, Eleanor Pullenayegum, Maureen Trudeau, ARCC Program (more…)